Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
basal insulin
Pharma
With strong data, Lilly plots filings for weekly insulin asset
With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.
Fraiser Kansteiner
Jun 23, 2025 10:16am
Novo Nordisk attracts lawmakers' ire for Levemir insulin pull
Apr 18, 2024 10:40am
Novo's long-lasting insulin candidate matches Lantus in phase 2
Jun 14, 2020 6:55pm
Sanofi's Toujeo tops Tresiba in tough-to-treat diabetes group
Jun 10, 2019 11:05am
Novo’s oral semaglutide could disrupt diabetes coverage: analyst
Mar 5, 2019 12:05pm
Mylan, Biocon inch closer to Lantus copycat launch
Dec 13, 2018 11:07am
